ABT (Abbott Laboratories) Cash Flow for Dividends: $-4,188 Mil (TTM As of Mar. 2026)


ABT Abbott Laboratories ABT
80 GF Score
Price $90.49
GF Value $129.49
Valuation Significantly Undervalued
View Full Analysis

What is Abbott Laboratories Cash Flow for Dividends?

Abbott Laboratories ABT -0.04% 80 Cash Flow for Dividends is $-4,188 Mil as of Mar. 2026. GuruFocus rates ABT with a GF Score™ of 80/100 and a GF Value™ of $129.49 (Significantly Undervalued).

Abbott Laboratories's cash flow for dividends for the three months ended in Mar. 2026 was $-1,098 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was $-4,188 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Abbott Laboratories's quarterly payment of dividends declined from Sep. 2025 ($-1,031 Mil) to Dec. 2025 ($-1,030 Mil) but then increased from Dec. 2025 ($-1,030 Mil) to Mar. 2026 ($-1,098 Mil).

Abbott Laboratories's annual payment of dividends increased from Dec. 2023 ($-3,556 Mil) to Dec. 2024 ($-3,836 Mil) and increased from Dec. 2024 ($-3,836 Mil) to Dec. 2025 ($-4,116 Mil).

Abbott Laboratories Cash Flow for Dividends Related Terms

Abbott Laboratories Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories Cash Flow for Dividends Chart

Abbott Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,202.00 -3,309.00 -3,556.00 -3,836.00 -4,116.00

Abbott Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,026.00 -1,029.00 -1,031.00 -1,030.00 -1,098.00
ABT
80GF Score
Abbott Laboratories ABT
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4,188 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of $-4,188 Mil mean?
Abbott Laboratories (ABT) has a Cash Flow for Dividends of $-4,188 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Abbott Laboratories and its competitors.
Is Abbott Laboratories' Cash Flow for Dividends too high?
Abbott Laboratories' current Cash Flow for Dividends is $-4,188 Mil. Overall, Abbott Laboratories has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Cash Flow for Dividends compare to SYK and MDT?
Abbott Laboratories' Cash Flow for Dividends of $-4,188 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Devices & Instruments company?
A good Cash Flow for Dividends depends on the Medical Devices & Instruments industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Abbott Laboratories and its competitors. Abbott Laboratories's current Cash Flow for Dividends is $-4,188 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (ABT) is currently considered Significantly Undervalued. The stock's GF Value™ is $129.49, compared to a current price of $90.49 — trading 30.1% below its estimated fair value. The current Cash Flow for Dividends is $-4,188 Mil. Abbott Laboratories' overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Abbott Laboratories (ABT), the current Cash Flow for Dividends is $-4,188 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of $90.49 is trading 30.1% below its estimated GF Value™ of $129.49. GuruFocus considers Abbott Laboratories to be Significantly Undervalued.

Key valuation signals for ABT:

  • Cash Flow for Dividends: $-4,188 Mil
  • GF Value™: $129.49 vs. price of $90.49 (30.1% below fair value)
  • GF Score™: 80/100

No single metric tells the full story. See the ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score

Get the complete analysis for ABT

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$90.49
Price
$129.49
GF Value